Metacrine Inc MTCR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:58 PM EST
0.55quote price arrow up+0.01 (+1.97%)
Volume
66,415
Close
0.5394quote price arrow down-0.0234 (-4.1578%)
Volume
1,368,041
52 week range
0.51 - 11.00
Loading...
  • Open0.556
  • Day High0.583
  • Day Low0.5331
  • Prev Close0.5628
  • 52 Week High11.00
  • 52 Week High Date02/16/21
  • 52 Week Low0.51
  • 52 Week Low Date01/10/22

Key Stats

  • Market Cap14.73M
  • Shares Out27.31M
  • 10 Day Average Volume1.75M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-19.99

KEY STATS

  • Open0.556
  • Day High0.583
  • Day Low0.5331
  • Prev Close0.5628
  • 52 Week High11.00
  • 52 Week High Date02/16/21
  • 52 Week Low0.51
  • 52 Week Low Date01/10/22
  • Market Cap14.73M
  • Shares Out27.31M
  • 10 Day Average Volume1.75M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-19.99

RATIOS/PROFITABILITY

  • EPS (TTM)-2.26
  • P/E (TTM)-0.24
  • Fwd P/E (NTM)-0.25
  • EBITDA (TTM)-58.305M
  • ROE (TTM)-81.90%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)20.30%

EVENTS

  • Earnings Date03/16/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Metacrine Inc

There is no recent news for this security.

Profile

MORE
Metacrine, Inc. is a United States-based biotechnology company. The Company is engaged in developing therapeutics for metabolic diseases. The Company leverages approximately two mechanistically distinct programs to target type 2 diabetes, NASH and other metabolic diseases and liver disorders. The Company focuses on advancing research in nuclear hormone receptors for treatment of metabolic diseases.
Richard Heyman Ph.D.
Independent Chairman of the Board
Preston Klassen M.D.
President, Chief Executive Officer, Director
Trisha Millican CPA
Chief Financial Officer
Catherine Lee
Executive Vice President, General Counsel, Corporate Secretary
Address
3985 Sorrento Valley Blvd., Suite C
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
TRVI
Trevi Therapeutics Inc
0.6987-0.02-2.7828%
FWBI
First Wave BioPharma Inc
1.35-0.06-4.26%
PSTV
Plus Therapeutics Inc
0.9919-0.0381-3.699%
PHIO
Phio Pharmaceuticals Corp
0.88-0.0041-0.4637%
PALI
Palisade Bio Inc
1.21-0.09-6.92%